TFPI Antibody - #DF6511
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF6511, RRID:AB_2838473.
折りたたみ/展開
Anti convertin; EPI; Extrinsic pathway inhibitor; LACI; Lipoprotein associated coagulation inhibitor; Lipoprotein-associated coagulation inhibitor; TFI; TFPI 1; TFPI; TFPI1; TFPI1_HUMAN; Tissue factor pathway inhibitor (lipoprotein associated coagulation inhibitor); Tissue factor pathway inhibitor;
免疫原
- P10646 TFPI1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MIYTMKKVHALWASVCLLLNLAPAPLNADSEEDEEHTIITDTELPPLKLMHSFCAFKADDGPCKAIMKRFFFNIFTRQCEEFIYGGCEGNQNRFESLEECKKMCTRDNANRIIKTTLQQEKPDFCFLEEDPGICRGYITRYFYNNQTKQCERFKYGGCLGNMNNFETLEECKNICEDGPNGFQVDNYGTQLNAVNNSLTPQSTKVPSLFEFHGPSWCLTPADRGLCRANENRFYYNSVIGKCRPFKYSGCGGNENNFTSKQECLRACKKGFIQRISKGGLIKTKRKRKKQRVKIAYEEIFVKNM
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P10646 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S30 | Phosphorylation | P68400 (CSNK2A1) | Uniprot |
T42 | O-Glycosylation | Uniprot | |
T115 | O-Glycosylation | Uniprot | |
T116 | O-Glycosylation | Uniprot | |
K121 | Ubiquitination | Uniprot | |
N145 | N-Glycosylation | Uniprot | |
N195 | N-Glycosylation | Uniprot | |
S202 | O-Glycosylation | Uniprot | |
S202 | Phosphorylation | P28482 (MAPK1) | Uniprot |
T203 | O-Glycosylation | Uniprot | |
T219 | Phosphorylation | Uniprot | |
K260 | Ubiquitination | Uniprot | |
K268 | Acetylation | Uniprot | |
K269 | Acetylation | Uniprot | |
K269 | Sumoylation | Uniprot | |
K293 | Sumoylation | Uniprot |
研究背景
Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma.
O-glycosylated.
Secreted.
Microsome membrane>Lipid-anchor.
Mostly in endothelial cells.
This inhibitor contains three inhibitory domains. The first domain interacts with VIIa and TF, the second one with Xa.
研究領域
· Organismal Systems > Immune system > Complement and coagulation cascades. (View pathway)
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.